Provided by Tiger Fintech (Singapore) Pte. Ltd.

Miragen Therapeutics, Inc.

23.01
0.0000
Volume:- -
Turnover:- -
Market Cap:89.93M
PE:-2.38
High:23.01
Open:23.01
Low:23.01
Close:23.01
Loading ...
Jul 26, 2021

Major Issues Report

8-K - Current report
Jul 15, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jun 04, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 17, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Apr 26, 2021

Major Issues Report

8-K - Current report
Mar 26, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2021

Major Issues Report

8-K - Current report
Mar 15, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals